Literature DB >> 26186709

Proteomic methods for biomarker discovery and validation. Are we there yet?

Yetrib Hathout1.   

Abstract

Noninvasive molecular biomarkers are becoming attractive tools to monitor disease progression, aid drug development programs and use as surrogate outcome measures in clinical trials. Cutting edge proteomic methods to assay biomarkers in body fluids have been developed in the past few years, but transitioning them to clinical practice has been slow and depends on the qualification of both the method and the biomarker.

Entities:  

Keywords:  SomaScan; antibody bead arrays; biomarkers; biomarkers validation; proteomics; targeted mass spectrometry

Mesh：

Substances：

Year:  2015        PMID： 26186709     DOI： 10.1586/14789450.2015.1064771

Source DB:  PubMed          Journal:  Expert Rev Proteomics        ISSN： 1478-9450            Impact factor:   3.940


  11 in total

Review 1.  Clinical utility of serum biomarkers in Duchenne muscular dystrophy.

Authors:  Yetrib Hathout; Haeri Seol; Meng Hsuan J Han; Aiping Zhang; Kristy J Brown; Eric P Hoffman
Journal:  Clin Proteomics       Date:  2016-04-05       Impact factor: 3.988

2.  Serum pharmacodynamic biomarkers for chronic corticosteroid treatment of children.

Authors:  Yetrib Hathout; Laurie S Conklin; Haeri Seol; Heather Gordish-Dressman; Kristy J Brown; Lauren P Morgenroth; Kanneboyina Nagaraju; Christopher R Heier; Jesse M Damsker; John N van den Anker; Erik Henricson; Paula R Clemens; Jean K Mah; Craig McDonald; Eric P Hoffman
Journal:  Sci Rep       Date:  2016-08-17       Impact factor: 4.379

3.  Metabolic profiling-multitude of technologies with great research potential, but (when) will translation emerge?

Authors:  Mika Ala-Korpela; George Davey Smith
Journal:  Int J Epidemiol       Date:  2016-10-27       Impact factor: 7.196

4.  A Comprehensive Proteomic SWATH-MS Workflow for Profiling Blood Extracellular Vesicles: A New Avenue for Glioma Tumour Surveillance.

Authors:  Susannah Hallal; Ali Azimi; Heng Wei; Nicholas Ho; Maggie Yuk Ting Lee; Hao-Wen Sim; Joanne Sy; Brindha Shivalingam; Michael Edward Buckland; Kimberley Louise Alexander-Kaufman
Journal:  Int J Mol Sci       Date:  2020-07-03       Impact factor: 5.923

5.  Genome and epigenome wide studies of neurological protein biomarkers in the Lothian Birth Cohort 1936.

Authors:  Robert F Hillary; Daniel L McCartney; Sarah E Harris; Anna J Stevenson; Anne Seeboth; Qian Zhang; David C Liewald; Kathryn L Evans; Craig W Ritchie; Elliot M Tucker-Drob; Naomi R Wray; Allan F McRae; Peter M Visscher; Ian J Deary; Riccardo E Marioni
Journal:  Nat Commun       Date:  2019-07-18       Impact factor: 14.919

Review 6.  Urinary proteomics and metabolomics studies to monitor bladder health and urological diseases.

Authors:  Zhaohui Chen; Jayoung Kim
Journal:  BMC Urol       Date:  2016-03-22       Impact factor: 2.264

7.  The potential clinical impact of the release of two drafts of the human proteome.

Authors:  Iakes Ezkurdia; Enrique Calvo; Angela Del Pozo; Jesús Vázquez; Alfonso Valencia; Michael L Tress
Journal:  Expert Rev Proteomics       Date:  2015-10-23       Impact factor: 3.940

Review 8.  The Challenge of Human Spermatozoa Proteome: A Systematic Review.

Authors:  Kambiz Gilany; Arash Minai-Tehrani; Mehdi Amini; Niloofar Agharezaee; Babak Arjmand
Journal:  J Reprod Infertil       Date:  2017 Jul-Sep

9.  Quantitative screening of serum protein biomarkers by reverse phase protein arrays.

Authors:  Zhizhou Kuang; Ruochun Huang; Zhimin Yang; Zhiqiang Lv; Xinyan Chen; Fuping Xu; Yu-Hua Yi; Jian Wu; Ruo-Pan Huang
Journal:  Oncotarget       Date:  2018-08-24

10.  A proteomic signature that reflects pancreatic beta-cell function.

Authors:  Aoife M Curran; Marie Pier Scott-Boyer; Jim Kaput; Miriam F Ryan; Elaine Drummond; Eileen R Gibney; Michael J Gibney; Helen M Roche; Lorraine Brennan
Journal:  PLoS One       Date:  2018-08-30       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.